Skip to main content

Table 4 The distribution of the Structured Interview for the Five-Factor Model of Personality among the studied samples

From: Effect of long-term administration of clonazepam, carbamazepine, and valproate on cognitive, psychological, and personality changes in adult epilepsy: a case–control study

Variables

Group 1

N = 35

N (%)

Group 2

N = 18

N (%)

Group 3

N = 31

N (%)

Group 4

N = 15

N (%)

Group 5

N = 40

N (%)

P value

Neuroticism

 Low

8 (22.86%)

0 (0%)

0 (0 %)

3 (20%)

10 (25%)

0.017*

 Intermediate

23 (65.71)

18 (100%)

29 (93.55%)

12 (80%)

28 (70%)

 

 High

4 (11.43%)

0 (0%)

2 (6.45%)

0 (0%)

2 (5%)

 

Extraversion

 Low

9 (25.7%)

0 (0%)

8 (25.8%)

0 (0%)

6 (15%)

0.002*

 Intermediate

26 (74.3%)

15 (83.3%)

23 (74.2%)

15 (100%)

27 (67.5%)

 

 High

0 (0%)

3 (16.7%)

0 (0%)

0 (0%)

7 (17.5%)

 

Openness to experience

 Low

26 (74.3%)

9 (50%)

28 (90.3%)

12 (80%)

29 (72.5%)

0.038*

 Intermediate

9 (25.7%)

9 (50%)

3 (9.7%)

3 (20%)

11 (27.5%)

 

Agreeableness

      

 Low

2 (5.7%)

0 (0%)

1 (3.2%)

0 (0%)

4 (10%)

0.614

 Intermediate

32 (91.4%)

18 (100%)

29 (93.5%)

15 (100%)

36 (90%)

 

 High

1 (2.9%)

0 (0%)

1 (3.2%)

0 (0%)

0 (0%)

 

Conscientiousness

 Low

10 (28.6%)

0 (0%)

12 (38.7%)

0 (0%)

10 (25%)

0.025*

 Intermediate

24 (68.6%)

18 (100%)

19 (61.3%)

15 (100%)

30 (75%)

 

 High

1 (2.9%)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

 
  1. Group 1: carbamazepine, group 2: valproate, group 3: carbamazepine and clonazepam, group 4: valproate and clonazepam, group 5: epileptic patients without antiepileptic drugs (AEDs), *significant P value